Vanberra Signal

Apotheca Biosciences

Curated by Signal

Cannabinoid-based control released topical formulations

Overview

Apotheca Biosciences is developing pharmaceuticals & nutraceuticals formulation and delivery technologies for the healthcare and consumer care industry. The companies pipeline products include transdermal, sublingual, and nasal delivery technologies for controlled dosing of cannabinoids. The company is developing cannabinoid-based formulations for the indications such as adjuvant therapy for opioid addiction, chronic pain, migraine, acne, dermatitis, anxiety, depression & chronic weight loss. The two products named as Canna-Derme opioid & Canna-Derme are clinical efficacy stage for opioid addiction & chronic pain respectively. Also developing nutraceutical products such as Health Hemp Bar & SmartHealth CBD Oil.

Key facts

Founded
2014

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • AI and cloud-based value-based care management tool

    Health TechnologyLouisville, United States
  • Provider of telemedicine and communication solutions for doctors

    Health TechnologyBaltimore, United States
  • Provider of telehealth software and remote patient monitoring device for doctors

    Health TechnologyBoca Raton, United States

About Apotheca Biosciences

What does Apotheca Biosciences do?

Apotheca Biosciences is developing pharmaceuticals & nutraceuticals formulation and delivery technologies for the healthcare and consumer care industry.

Where is Apotheca Biosciences headquartered?

Apotheca Biosciences is headquartered in Sarasota, United States.

When was Apotheca Biosciences founded?

Apotheca Biosciences was founded in 2014.

Which sector is Apotheca Biosciences in?

Apotheca Biosciences operates in Health Technology.

Who are Apotheca Biosciences's competitors?

Companies similar to Apotheca Biosciences include RAAPID, GoMCN, and Clear Arch Health.